Clinical Trial Update: Evaluating the Safety of and Immune Response to a Dengue Vaccine (TV003) in Healthy Adults, Adolescents, and Children in Thailand [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing safety and immune response of the dengue vaccine TV003 in healthy adults, adolescents, and children in Thailand (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue

Drugs mentioned

• TV003

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Dengue | Phase 2 | Status: COMPLETED